Improving Decision Making for Patients With Prolonged Mechanical Ventilation
- Conditions
- Prolonged Mechanical VentilationSurrogate Decision Makers
- Interventions
- Other: Usual careBehavioral: Decision aid
- Registration Number
- NCT01751061
- Lead Sponsor
- Duke University
- Brief Summary
Deciding about prolonged life support for critically ill patients can be very difficult. Therefore, the investigators are doing a study to see if an internet-based decision aid can improve the quality of decision making for substitute decision makers of patients who are in the intensive care unit (ICU).
- Detailed Description
The process of making a decision about whether or not to provide prolonged life support is seriously deficient among clinicians and the surrogate decision makers for critically ill patients. To address this problem, we propose a randomized, controlled trial to determine if an innovative web-based decision aid compared to usual care control can improve the quality of decision making (defined as clinician-surrogate concordance for prognosis, quality of communication, and medical comprehension), reduce surrogates' psychological distress (depression, anxiety, and post-traumatic stress syndrome disorder (PTSD) symptoms), and reduce patients' health care costs over 6-month follow up. We will enroll 410 surrogate decision makers for 273 patients (expected average of 1.5 surrogates per patient). This study has the potential both to improve how clinicians and surrogates interact in intensive care units and to increase the likelihood that life support decisions are aligned with patients' values.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 416
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Usual care Usual care usual care in an intensive care unit setting Decision aid Decision aid Web-based decision aid (decision support tool) provided to surrogate decision maker
- Primary Outcome Measures
Name Time Method Change in Clinician-surrogate Concordance Scale Score ~2-7 days post-randomization Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the surrogate(s) and the clinician (ICU physician), and, therefore, can range from 0 to 100.
We report pre-intervention to post-intervention difference in the CSCS.
The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of either the treating ICU physician (primary outcome) or the nurse (secondary outcome) to the question, "What percent chance do you think \[the patient/your loved one\] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.
- Secondary Outcome Measures
Name Time Method Post-traumatic Stress Syndrome Inventory Pre-randomization (study day 1) and 180 days post-randomization Here we report PTSS score differences between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary (not secondary) surrogate decision makers.
PTSS scores can range from 10-70, with greater scores=more distress.Patient-centeredness of Care Scale Study day 1 and 180 days post-randomization Here we report change in patient-centeredness score between Study day 1 (Interview 1) and 180 days post-randomization (Interview 4) for primary (not secondary) surrogate decision makers.
Scores can range from 12-48 points, with higher scores=greater patient-centeredness.Quality of Communication Scale Score Study day 1 (pre-randomization), ~2-7 Here we report QOC score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.
Scores range from 0-110, with higher scores=better quality of communication.Medical Comprehension Scale Score Study day 1 (pre-randomization), ~2-7 Here we report MCS score differences between Interview 1 (baseline) and Interview 2 (immediately post-intervention) for primary (not secondary) surrogate decision makers.
Scores can range from 0-8, with greater scores=better comprehension.Hospital Anxiety and Depression Scale (HADS) Total Score Pre-randomization (study day 1) and 180 days post-randomization We report here the difference between Interview 1 (baseline) and Interview 4 (6 months post-randomization) for primary surrogate decision makers (not secondary).
HADS scores can range from 0 to 42 points; higher scores=more distress.Change in Clinical-surrogate Concordance Scale Score (Nurse) ~2-7 days post-randomization Concordance is calculated as the absolute value of the difference in prognosis for 1 year patient survival between the primary surrogate decision maker and the IUC nurse, and, therefore, can range from 0 to 100.
We report pre-intervention to post-intervention difference in the CSCS.
The CSCS is calculated as the absolute value of the difference between the surrogate's response and that of the nurse to the question, "What percent chance do you think \[the patient/your loved one\] has of being alive 1 year from now if the current treatment plan is continued?" Scores can range from 0 to 100 percentage points, and higher values indicate greater discordance.
Trial Locations
- Locations (4)
University of North Carolina
🇺🇸Chapel Hill, North Carolina, United States
University of Pittsburgh
🇺🇸Pittsburgh, Pennsylvania, United States
Duke University
🇺🇸Durham, North Carolina, United States
University of Washington
🇺🇸Seattle, Washington, United States